Publications
Publications
- March 1997
- HBS Case Collection
BioTransplant, Inc.: Initial Public Offering, January 1996
By: Paul A. Gompers and Alexander Tsai
Abstract
Examines the decision to go public. BioTransplant is an early stage biotechnology company that must decide how to finance its research and development. The pros and cons of public offerings are analyzed versus alternative financing sources.
Keywords
Citation
Gompers, Paul A., and Alexander Tsai. "BioTransplant, Inc.: Initial Public Offering, January 1996." Harvard Business School Case 297-095, March 1997.